Literature DB >> 30198179

The torg ratio of C3-C7 in African Americans and European Americans: A skeletal study.

David Ezra1,2, Viviane Slon1, Einat Kedar1, Youssef Masharawi3, Khalil Salame4, Deborah Alperovitch-Najenson1, Israel Hershkovitz1.   

Abstract

The ratio between the sagittal diameter of the spinal canal and the sagittal diameter of the vertebral body, known as the "Torg ratio", is often used to test for spinal canal narrowing. Here, we investigate this ratio in a large population, consisting of two ethnicities, both sexes and three age groups. Measurements were taken on the dry cervical verterbrae (C3-C7) of 277 individuals using a digital apparatus allowing for the recording of 3D coordinates of a set of landmarks on the vertebral body. Vertebral body and vertebral foramen lengths were compared across the different subgroups. Vertebral body and vertebral foramen lengths differ significantly between males and females and between African Americans and European Americans. With age, the vertebral body length increases while the foramen length does not undergo significant changes. These anatomical differences are reflected in differences in the Torg ratio calculated for the different subgroups. In conclusion, our findings suggest that a hard cutoff on the Torg ratio used to define a pathological narrowing of the cervical spine should be adapted to the population the patients come from. Clin. Anat. 32: 84-89, 2019.
© 2018 Wiley Periodicals, Inc. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Torg-Pavlov ratio; cervical spine; spinal stenosis; vertebral body; vertebral foramen

Mesh:

Year:  2019        PMID: 30198179     DOI: 10.1002/ca.23269

Source DB:  PubMed          Journal:  Clin Anat        ISSN: 0897-3806            Impact factor:   2.414


  1 in total

1.  A comparative shape analysis of the cervical spine between individuals with cervicogenic headaches and asymptomatic controls.

Authors:  Youssef Masharawi; Aumayma Murad Mansour; Natan Peled; Asaf Weisman
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.